Takeda Pharmaceutical (TAK) Financials: Revenue & Earnings
Score
Financial Summary
Takeda Pharmaceutical Company Limited (TAK) last printed $21.41. Equity value is $69.55B. Trailing earnings multiple 28.48. The revenue row is reported history.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| $1.73T | $1.77T | $2.1T | $3.29T | $3.2T | $3.57T | $4.03T | $4.26T | $4.58T | $4.51T |